ArticleJournal for immunotherapy of cancer2024

Off-the-shelf CAR-NK cells targeting immunogenic cell death marker ERp57 execute robust antitumor activity and have a synergistic effect with ICD inducer oxaliplatin.

Liuhai Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.